Medroxyprogesterone acetate
Pro Research Analysisby 
Searched over 200M research papers for "medroxyprogesterone acetate"
Medroxyprogesterone Acetate: Pharmacologic Properties and Clinical Uses
Medroxyprogesterone acetate (MPA) is a synthetic progestogen, derived from progesterone, and is used in various clinical settings including contraception, hormone therapy, and reproductive medicine. It is available in both oral and injectable forms and is active via both routes of administration .
Contraceptive Efficacy and Safety of Depot-Medroxyprogesterone Acetate
Depot-medroxyprogesterone acetate (DMPA), marketed as Depo-Provera, is a long-acting injectable contraceptive that is highly effective and does not require daily administration. Decades of clinical use have established its safety profile, with long-term studies showing it is generally safe for most women. However, patient management should consider potential effects on menstrual cycles, body weight, and mood, as well as rare risks such as osteopenia and possible associations with certain cancers Westhoff2003Wang2025.
Medroxyprogesterone Acetate in Assisted Reproduction and Oocyte Donation
MPA is an effective oral alternative to gonadotropin-releasing hormone (GnRH) antagonists for preventing premature luteinizing hormone (LH) surges during controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF) cycles. Studies show that MPA provides similar outcomes in terms of oocyte retrieval, pregnancy rates, and live birth rates compared to traditional protocols, making it a patient-friendly option for both IVF and oocyte donation cycles Kuang2015Gilés2021.
Hormonal Contraception, Immune Function, and HIV-1 Susceptibility
Research indicates that MPA can suppress both innate and adaptive immune responses by reducing the production of key cytokines and chemokines. This immunosuppressive effect may contribute to an increased risk of HIV-1 acquisition and transmission among women using DMPA, as MPA also impairs the integrity of the vaginal epithelial barrier, further increasing susceptibility to infection Huijbregts2013Woods2020.
Neurological and Cognitive Effects of Medroxyprogesterone Acetate
MPA and its metabolites can modulate specific subtypes of GABAA receptors in the brain, which are involved in memory, cognition, and mood regulation. Chronic use of MPA has been linked to cognitive impairment and increased risk of dementia in women, likely due to its effects on the GABAergic system .
Adverse Events and Long-Term Safety Concerns
Pharmacovigilance data from the FDA Adverse Event Reporting System highlight a range of adverse events associated with MPA, including expected risks such as breast and ovarian cancer, as well as unexpected events like acquired diaphragmatic eventration. The data suggest the need for ongoing monitoring and further research to clarify these associations and ensure patient safety .
Association with Meningioma Risk
Recent large-scale studies have found that injectable MPA is associated with an increased risk of cerebral meningioma, particularly with prolonged use. This risk does not appear to extend to oral MPA or to spinal meningiomas, but women should be cautioned about long-term use of injectable MPA .
Medroxyprogesterone Acetate in Gender-Affirming Therapy
In transgender women, MPA is used as part of feminizing hormone therapy. It has been shown to lower testosterone levels significantly without affecting estradiol levels, and most patients report minimal side effects. Some individuals experience improved breast development and reduced facial hair, though mood swings can occur in a minority of users .
Conclusion
Medroxyprogesterone acetate is a versatile progestin with established roles in contraception, reproductive medicine, and gender-affirming therapy. While it is generally effective and well-tolerated, clinicians and patients should be aware of its potential effects on immune function, neurological health, and long-term risks such as meningioma and certain cancers. Ongoing research and careful patient selection are essential to maximize benefits and minimize risks associated with MPA use.
Sources and full results
Most relevant research papers on this topic